The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging
- PMID: 34089901
- DOI: 10.1016/j.arr.2021.101376
The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging
Abstract
Aging can not only shorten a healthy lifespan, but can also lead to multi-organ dysfunction and failure. Anti-aging is a complex and worldwide conundrum for eliminating the various pathologies of senility. The past decade has seen great progress in the understanding of the aging-associated signaling pathways and their application for developing anti-aging approaches. Currently, some drugs can improve quality of life. The activation of mammalian target of rapamycin (mTOR) signaling is one of the core and detrimental mechanisms related to aging; rapamycin can reduce the rate of aging, improve age-related diseases by inhibiting the mTOR pathway, and prolong lifespan and healthspan effectively. However, the current evidence for rapamycin in lifespan extension and organ aging is fragmented and scattered. In this review, we summarize the efficacy and safety of rapamycin in prolonging a healthy lifespan by systematically alleviating aging in multiple organ systems, i.e., the nervous, urinary, digestive, circulatory, motor, respiratory, endocrine, reproductive, integumentary and immune systems, to provide a theoretical basis for the future clinical application of rapamycin in anti-aging.
Keywords: Adverse effects; Healthspan; Organ aging; Rapamycin; mTOR signaling.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
Next Generation Strategies for Geroprotection via mTORC1 Inhibition.J Gerontol A Biol Sci Med Sci. 2020 Jan 1;75(1):14-23. doi: 10.1093/gerona/glz056. J Gerontol A Biol Sci Med Sci. 2020. PMID: 30794726 Free PMC article. Review.
-
Rapamycin in aging and disease: maximizing efficacy while minimizing side effects.Oncotarget. 2016 Jul 19;7(29):44876-44878. doi: 10.18632/oncotarget.10381. Oncotarget. 2016. PMID: 27384492 Free PMC article.
-
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice.Elife. 2016 Aug 23;5:e16351. doi: 10.7554/eLife.16351. Elife. 2016. PMID: 27549339 Free PMC article.
-
Rapamycin improves healthspan but not inflammaging in nfκb1-/- mice.Aging Cell. 2019 Feb;18(1):e12882. doi: 10.1111/acel.12882. Epub 2018 Nov 23. Aging Cell. 2019. PMID: 30468013 Free PMC article.
-
TOR Signaling Pathway in Cardiac Aging and Heart Failure.Biomolecules. 2021 Jan 27;11(2):168. doi: 10.3390/biom11020168. Biomolecules. 2021. PMID: 33513917 Free PMC article. Review.
Cited by
-
Novel Advances in Cell-Free Therapy for Premature Ovarian Failure (POF): A Comprehensive Review.Adv Pharm Bull. 2024 Oct;14(3):543-557. doi: 10.34172/apb.2024.059. Epub 2024 Jul 31. Adv Pharm Bull. 2024. PMID: 39494249 Free PMC article. Review.
-
Apple polysaccharide improves age-matched cognitive impairment and intestinal aging through microbiota-gut-brain axis.Sci Rep. 2024 Jul 13;14(1):16215. doi: 10.1038/s41598-024-67132-4. Sci Rep. 2024. PMID: 39003416 Free PMC article.
-
Effects of anti-aging interventions on intestinal microbiota.Gut Microbes. 2021 Jan-Dec;13(1):1994835. doi: 10.1080/19490976.2021.1994835. Gut Microbes. 2021. PMID: 34743658 Free PMC article. Review.
-
Anti-Aging Effect of Momordica charantia L. on d-Galactose-Induced Subacute Aging in Mice by Activating PI3K/AKT Signaling Pathway.Molecules. 2022 Jul 14;27(14):4502. doi: 10.3390/molecules27144502. Molecules. 2022. PMID: 35889375 Free PMC article.
-
Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis.Front Immunol. 2022 Oct 6;13:946832. doi: 10.3389/fimmu.2022.946832. eCollection 2022. Front Immunol. 2022. PMID: 36275654 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
